EDGAR Filing Documents for 0001140361-22-038147

Form 8-K - Current report:

SEC Accession No. 0001140361-22-038147

Filing Date

2022-10-24

Accepted

2022-10-24 06:09:50

Documents

Period of Report

2022-10-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	ny20005635x1_8k.htm iXBRL	8-K	46213
2	EXHIBIT 2.1	ny20005635x1_ex2-1.htm	EX-2.1	628460
3	EXHIBIT 10.1	ny20005635x1_ex10-1.htm	EX-10.1	60099
4	EXHIBIT 99.1	ny20005635x1_ex99-1.htm	EX-99.1	24020
5	EXHIBIT 99.2	ny20005635x1_ex99-2.htm	EX-99.2	14107
6	EXHIBIT 99.3	ny20005635x1_ex99-3.htm	EX-99.3	11443
10		ny20005635x1_ex2-1img01.jpg	GRAPHIC	2478
	Complete submission text file	0001140361-22-038147.txt		1127049

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	myov-20221023.xsd	EX-101.SCH	3863
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	myov-20221023_lab.xml	EX-101.LAB	22547
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	myov-20221023_pre.xml	EX-101.PRE	16043
12	EXTRACTED XBRL INSTANCE DOCUMENT	ny20005635x1_8k_htm.xml	XML	4208

Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB

Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351

Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)